Medicine & Health

A team of neuroscientists and engineers, including some at the School of Medicine, has developed a tiny, implantable device that has potential to help people with bladder problems bypass the need for medication or electronic stimulators.

Researchers at the School of Medicine have found that the same mutation that gives tuberculosis bacteria drug resistance also elicits a weaker immune response. The findings are published in Nature Microbiology.

A new School of Medicine study shows that children born with neurofibromatosis (NF1), a common genetic syndrome, are much more likely to have brain tumors than previously thought.

Longtime supporters of the medical school, Debra and George Couch are focused now on helping advance discoveries through precision medicine.

Parkinson’s disease is caused by the injury or death of brain cells known as dopaminergic neurons. A new School of Medicine study shows that people who take drugs that suppress the immune system are less likely to develop the disease, which is characterized by difficulty with movement.

School of Medicine researchers report they found a way to treat urinary tract infections without using antibiotics, at least in mice. The scientists are working on an alternative that would prevent bacteria from causing disease.

Why move from current standards of patient care to a more personalized approach to treatment? Experts at the School of Medicine describe today’s medical landscape as they plan for the care — and cures — of the future.

The School of Medicine is building the necessary infrastructure through centers and institutes to allow research that is more efficient and cost-effective, and that encourages high risks leading possibly to key breakthroughs.

Timothy Ley, MD, has been investigating leukemia, particularly acute myeloid leukemia (AML), for decades. His research team now knows the mutations they need to go after ­aggressively, the nature of the ­mutations that need to be targeted and why patients relapse.

At Washington University, training the next generation of leaders in translational medicine is a key focus. Here, Cheryl Leyns and Phat Huynh share stories of working in the lab of David Holtzman, MD, researching pathologies of Alzheimer’s disease.